ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models.

Marianela Candolfi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.